For visual reference only; actual product may vary
For visual reference only; actual product may vary
Aubagio (Teriflunomide) is a prescription oral tablet used once a day to treat relapsing forms of multiple sclerosis (MS) in adults. By calming an overactive immune system, it helps to lower the number of flare-ups and slow the worsening of physical disability associated with MS.
Shipping of this product to the U.S. is currently paused due to new postal regulations affecting shipments into the United States. Please rest assured that we are actively addressing these new requirements.
To be notified when shipping resumes, please join our waitlist.
| Aubagio Brand | 14mg 28 Tablets |
-
|
Our price: $1,016.00 |
Aubagio is a brand-name prescription medication used to treat adults with relapsing forms of multiple sclerosis (MS), including clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease. Its active ingredient is teriflunomide. As an immunomodulatory agent, it works by calming the immune system to prevent it from attacking the nerves in your brain and spinal cord, which is the cause of MS symptoms. This action helps to reduce the frequency of MS relapses and delay the accumulation of physical disability over time. Aubagio is taken as a once-daily oral tablet, making it a convenient long-term treatment option for managing this chronic condition.
Aubagio works by inhibiting a specific enzyme called dihydroorotate dehydrogenase, which is crucial for the creation of new DNA in rapidly dividing cells, particularly the white blood cells known as lymphocytes. In multiple sclerosis, these lymphocytes mistakenly attack the myelin sheath that protects nerve fibers in the central nervous system. By blocking the enzyme, Aubagio limits the proliferation of these active T and B lymphocytes. This reduction in the number of available immune cells leads to a decrease in the inflammation and damage to the central nervous system, ultimately resulting in fewer MS relapses and a slower progression of the disease.
Aubagio is for adults who have been diagnosed with a relapsing form of multiple sclerosis. This includes individuals who have experienced their first clinical episode (clinically isolated syndrome) and have MRI features consistent with MS, those with relapsing-remitting MS (RRMS) who experience clear flare-ups followed by periods of recovery, and those with active secondary progressive MS (SPMS) who still have relapses. It is intended for patients seeking an oral, once-daily medication to manage their condition and is not for use in children or adolescents. Patients should have adequate liver function and discuss their full medical history with their doctor before starting treatment.
The dosage and administration of Aubagio should be strictly followed as prescribed by your healthcare provider. It is typically taken as a single oral tablet once a day, with or without food, and is available in two strengths: 7 mg and 14 mg. The specific dose a patient receives depends on their doctor’s assessment of their clinical condition and tolerance for the medication. It is important to swallow the tablet whole and not to stop taking Aubagio without first consulting your doctor, as the medication stays in the body for a long time after discontinuation. Your doctor will perform blood tests to check your liver function before you start and periodically during treatment.
Like all medications, Aubagio may cause side effects, though not everyone will experience them. The most common side effects include headache, a temporary increase in hair thinning or loss, diarrhea, nausea, a decrease in white blood cell count, and an increase in liver enzymes. More serious side effects can occur, such as severe liver problems, high blood pressure, serious skin reactions, and nerve damage (peripheral neuropathy). It is critical to contact your doctor immediately if you experience symptoms like yellowing of the skin or eyes, dark urine, severe stomach pain, or unusual rash and blistering. Your healthcare provider will monitor you for potential side effects throughout your treatment.
Buying from IsraelPharm provides a reliable and cost-effective way to access your essential medications like Aubagio. We are a trusted online pharmacy that sources genuine, brand-name pharmaceuticals directly from authorized distributors, ensuring you receive the same high-quality medication you would at a local pharmacy. Our competitive pricing structure helps make long-term treatment more affordable. With a simple ordering process, discreet packaging, and dedicated customer support, IsraelPharm is committed to providing a secure and convenient service for patients managing chronic conditions like multiple sclerosis, helping you maintain your treatment regimen without interruption.
Aubagio can cause side effects, which may vary in severity. It’s important to discuss these with your doctor.
Common side effects may include:
More serious side effects can occur and require immediate medical attention. These include:
This is not a complete list of side effects. Always consult your healthcare provider for medical advice about adverse effects.
Aubagio (Teriflunomide) is a prescription medicine indicated for the treatment of adults with relapsing forms of multiple sclerosis (MS), which include:
The goal of treatment is to reduce the frequency of clinical exacerbations and to slow the accumulation of physical disability.
Send Your Prescription
No Hidden Fees
Generally 7-10 Business Days
IsraelPharm has been delivering lost cost prescriptions from Israel for over 15 years worldwide. Daily flights allow us to get your medications dispatched fast! Delivery to the USA is under 10 days and you can track and trace every order.
There’s a lot of talk on Capitol Hill about the need to address high drug prices and the spiraling cost of medications in the US. This is a subject that pops up quite regularly, perhaps in
A recent article from CNN Politics discusses the measures Medicare is taking to reduce the cost of medications that financially burden the agency. The title of the CNN Politics article tells just about all you
According to the US Federal government’s public data published in March 2023 on YouGov.com, more than one-third of Americans ignore their prescriptions or have not filled a prescription because of its cost. When a prescription
